Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    "Typhoid fever"
Show Display Options
RSS Create an RSS feed from your search for:
"Typhoid fever"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Understanding Typhoid Disease After Vaccination
Conditions: Typhoid Fever;   Enteric Fever;   Typhoid
Interventions: Biological: Vaccine placebo (excipients only);   Biological: Ty21a;   Biological: M10ZH09 vaccine
2 Active, not recruiting Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever
Conditions: Enteric Fever;   Typhoid Fever
Interventions: Drug: Ceftriaxone;   Drug: Gatifloxacin
3 Completed
Has Results
Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants
Condition: Typhoid Fever
Interventions: Biological: Vi-rEPA conjugate vaccine for typhoid fever;   Biological: Hib-TT;   Biological: DTP
4 Completed Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
Condition: Typhoid Fever
Intervention: Biological: Ty800 (Salmonella typhi) Oral Vaccine
5 Completed
Has Results
Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects
Conditions: Salmonella Infections;   Typhoid Fever;   Bacterial Infections
Intervention: Biological: Typhoid Vi polysaccharide
6 Completed Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A vaccine
7 Recruiting Typhoid Fever: Combined vs. Single Antibiotic Therapy
Condition: Typhoid Fever
Interventions: Drug: ceftriaxone;   Drug: ceftriaxone and azithromycin;   Drug: azithromycin;   Drug: azithromycin and cefixime
8 Completed Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Meningococcal A (control)
9 Completed Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A (control)
10 Completed Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A vaccine
11 Completed Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults
Condition: Typhoid
Interventions: Biological: M01ZH09;   Other: Placebo
12 Not yet recruiting Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study
Conditions: Typhoid Fever;   Paratyphoid Fever
Interventions: Biological: Salmonella Typhi;   Biological: Salmonella Paratyphi
13 Completed CVD 909 Vi Prime Boost Study
Condition: Typhoid Fever
Interventions: Biological: CVD 909;   Drug: Placebo;   Biological: Vi Polysaccharide
14 Completed TY800 Dose Escalation (Typhoid)
Condition: Typhoid and Paratyphoid Fevers
Interventions: Biological: Ty800;   Drug: Placebo
15 Completed Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
Conditions: Hepatitis B;   Typhoid;   Hepatitis A
Intervention: Biological: Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix
16 Completed Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age
Condition: Typhoid Fever
Intervention:
17 Completed Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine
Condition: Typhoid Fever
Intervention: Drug: BB IND 6989
18 Completed
Has Results
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)
Condition: Typhoid Fever
Interventions: Biological: Typherix;   Biological: NVGH Vi-CRM197
19 Completed
Has Results
Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults
Condition: Typhoid Fever
Intervention: Biological: NVGH Vi-CRM197
20 Completed
Has Results
Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
Condition: Typhoid Fever
Interventions: Biological: NVGH Vi-CRM197 12.5 mcg;   Biological: NVGH Vi-CRM197 5.0 mcg;   Biological: NVGH Vi-CRM197 1.25 mcg;   Biological: Vi-polysaccharide vaccine

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years